
==== Front
PeerJ
PeerJ
PeerJ
PeerJ
2167-8359
PeerJ Inc. San Diego, USA

18074
10.7717/peerj.18074
Global Health
Public Health
Mental Health
COVID-19
Rehabilitation
Effect of post COVID-19 on body composition, physical fitness, sleep quality and quality of life among young adults: a cross-sectional study of matched pairs
http://orcid.org/0000-0003-0176-4670
Srirug Phatcharawadee 12
Pongmala Chatkaew 3
Mayeedeng Balkis 1
Yusoh Nurulfatin 1
Malee Sofiya 1
http://orcid.org/0000-0002-2121-2403
Udom Chadayu 12uchadayu@mail.wu.ac.th

1 Department of Physical Therapy, School of Allied Health Sciences, Walailak University, Thasala, Nakhonsrithammarat, Thailand
2 Walailak University, Movement Science and Exercise Research Center, Nakhon Sri Thammarat, Thailand
3 Functional Neuroimaging, Cognitive, and Mobility Laboratory, Department of Radiology, University of Michigan, Michigan, United States
Albuquerque Ulysses
20 9 2024
2024
12 e1807419 1 2024
19 8 2024
© 2024 Srirug et al.
2024
Srirug et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Background

Coronavirus 2019 (COVID-19) causes lung tissue inflammation, affects mental health, and disturbs sleep and the musculoskeletal system. This study aimed to investigate the effects of COVID-19 on physical function and quality of life by comparing the body composition, physical fitness, sleep quality and quality of life between Thai young adults with and without post COVID-19 infection.

Methods

A cross-sectional study was comprised of two matched groups (post COVID-19 group and non COVID-19 group) with 36 participants in each group. Data about body composition, physical fitness, sleep quality and quality of life were collected using the bioelectrical impedance analysis, the 1-min sit-to-stand test, the hand grip strength test, the Pittsburgh sleep quality questionnaire and the EuroQol-5D-5L, respectively. Independent samples T-test, Mann-Whitney U test and Chi-square test were used to compare between the two groups.

Results

The changes in oxygen saturation and respiratory rate after the physical fitness test and the sleep quality analysis showed a statistically significant difference between the groups with and without post COVID-19 infection (p = 0.006, p = 0.003 and p = 0.003, respectively). However, quality of life and body composition were not significantly different between groups.

Conclusions

COVID-19 influenced the changes in oxygen saturation and respiratory rate after the physical fitness test and the sleep quality analysis in young adults. The results should be utilized to facilitate physical rehabilitation for COVID-19-infected individuals following infection. Those who have not been infected with COVID-19 must be informed of self-protection measures to avoid contracting the virus.

Physical fitness
Quality of life
Post COVID-19
Sleep quality
Body composition
Hand grip strength
The authors received no funding for this work.
==== Body
pmcIntroduction

Coronavirus disease 2019 (COVID-19) is a disease caused by exposure to the severe acute respiratory syndrome coronavirus 2 (SAR-COV-2), which began to spread in China since 2019. The number of infections increased in many countries. Therefore, the World Health Organization (WHO) declared an epidemic in March 2020. As of April 13, 2024, more than 704 million people worldwide have been infected and more than 7 million have died from COVID-19. Thailand has the 33rd highest number of infected people in the world, with a total of more than 4 million infected and more than 30,000 people who have died from COVID-19 (Worldometers, 2024).

When the body is infected with SAR-COV-2, it causes lung tissue inflammation. These include interstitial pneumonia and respiratory distress syndrome, which cause organs such as the heart, lungs, brain and nervous system to fail (Zhou et al., 2020). Furthermore, it affects mental health (anxiety and depression), disturbs sleep and the musculoskeletal system (pain and muscle weakness), and causes fatigue (WHO, 2020).

Recent studies have shown that some patients may develop complications from infection, and 11 to 24 percent of patients’ symptoms may last longer than 3 months after exposure (Cirulli et al., 2020; Ding et al., 2020; WHO, 2020). Therefore, it may reduce physical fitness and quality of life. In addition, after the COVID-19 infection has disappeared, patients may still have other symptoms. Symptoms are usually found 4 weeks or more after being infected, also known as the long Covid condition (Ladds et al., 2020). This could be a new symptom or a residual effect after treatment; and symptoms such as hypoxia, shortness of breath or dyspnea, decreased ability to work (reduced ability to work) (Bryson, 2021; Santus et al., 2020), and fatigue (Shanbehzadeh et al., 2021) may persist for more than or equal to 12 weeks. Factors affected by fatigue consist of conditional factors and physiological factors. The conditional factors include job characteristics, environment, and individual physical and mental abilities. The physiological factors include central factors (levels of neurotransmitters, neuron activation, inflammation, and multiple sclerosis), psychological factors (stress, anxiety, depression, and fear) and peripheral factors (skeletal muscle) (Rudroff et al., 2020).

Previous literature have reported that physical fitness and quality of life were studied in patients with COVID-19, but very few studied the effects of post COVID-19 infection (Rudroff et al., 2020). Factors affecting the symptoms of post COVID-19 patients include high blood pressure, obesity, mental health condition (Tenforde et al., 2020), age, associated comorbidities, severity of COVID-19 symptoms, and severity of COVID-19 infection (Sharma, Bharti & Garg, 2022). Therefore, this study aimed to examine the impact of COVID-19 infection on body composition, physical fitness and quality of life in Walailak University students who had recovered from COVID-19 infection in order to provide a guideline to raise awareness on preventative measures and physical rehabilitation after COVID-19 infection.

Materials and Methods

Participants and setting

This study is a cross-sectional study (Observational study: matched case-control). Data was collected from July to September 2022 at the Physical Therapy Research Laboratory, Walailak University. Walailak University granted ethical approval to carry out the study within its facilities (Ethical Application Ref: WUEC-22-204-01).

The study objectives, research process, and benefits to be gained from participating in the study were explained to all volunteers. Participants signed a consent form to participate in the study, and selection of participants was according to the inclusion and exclusion criteria. Data was collected from the research project participants who met the inclusion criteria (Fig. 1).

10.7717/peerj.18074/fig-1 Figure 1 Flow chart of participant recruitment.

The volunteers interested in participating in the study were screened, and those who could not understand the questionnaire and had peripheral blood oxygen saturation (SpO2) <95% were excluded from the study. The inclusion criteria of each group were as follows:

Post COVID-19 group: This group included Walailak University students, both male and female with normal range body mass index (BMI) from 18.5 to 22.9 kg/m2 (Supadanaison, Panklang & Seechumsang, 2019), who had been diagnosed with COVID-19 and had recovered or completed the quarantine period within 1–3 months after being infected. At least one symptom should remain. The average number of days since the COVID-19 infection was 50 days and ranged from 30 to 119 days.

Non COVID-19 group: This group included Walailak University students, both male and female with normal range BMI, who have never been diagnosed with COVID-19 infection.

Matched-pair analysis

Each analyzed case of the post COVID-19 group (n = 36) was matched with one non COVID-19 group (n = 36) applying matching criteria in the following prioritization order: gender, age and physical activity level. Because of these confounding factors, there was an effect on muscle integrity and may have a final effect on the body composition, grip strength, the 1-minute sit-to-stand test (1MSTS) and fatigue score.

Data collection

This study collected data in two parts. The first part was comprised of data collected by four questionnaires as follows: 1) general characteristics (including age, gender, weight, height, body mass index, waist circumference, physical activity level, smoking habit, average sleep duration within the past 1 year, behavior according to protective measures, number of vaccines received, and quarantine as a high-risk group); 2) the European Quality of Life five Dimensions five Level questionnaire (EuroQol-5D-5L) (Registration No. 49009), which has a good level of structural validity (Kimman et al., 2013). The score was classified into two levels: perfect health and not perfect health. Perfect health was defined with a score of one on each dimension, and not perfect health was defined as any other scores in one or more of the five dimensions; and 3) the Pittsburgh Sleep Quality questionnaire—Thai version (Pittsburgh sleep quality index score; PSQI score), which had a Cronbach’s alpha of 0.84, intraclass correlation coefficient of 0.89, sensitivity of 77.78%, specificity of 93.33%, and could be used to classify people with sleep problems (Sitasuwan et al., 2014). The score was classified into two levels: good sleep quality and poor sleep quality. Good sleep quality referred to a PSQI score of five or less, and poor sleep quality referred to a PSQI score greater than five. The second part was comprised of data collected by using the following: 1) the bioelectrical impedance analysis (BIA) (Tanita SC-330 Body Composition Analyzer; Tanita Corp., Tokyo, Japan) to assess body composition including body fat, muscle mass, visceral fat level (range from 1–59; 1–12 indicates a healthy level of visceral fat and 13–59 indicates an excess level of visceral fat), lean body mass and total body water; and 2) the physical fitness test including the 1-min sit-to-stand test (1MSTS) and the hand grip strength test, which was measured using a hand grip dynamometer (Takei TKK5001; Takei Scientific Instruments Co. Ltd, Tokyo, Japan) (Zaccagni et al., 2020). For hand grip strength, the participants were asked to use their dominant hand to squeeze the hand grip dynamometer as hard as they could and hold for 5 s, repeat three times, and rest 1 min each time; and the highest value was used. The 1MSTS (Bohannon & Crouch, 2019), with minimal important difference of three and ICC of 0.99, was used for the assessment of exercise capacity, which would be equivalent to the 6-min walk test (6MWT). The testing method was as follows: the participants were seated on armless and wall-mounted chairs, had arms crossed over chest, and asked to stand up and sit down for one round before starting the test. Blood pressure (mmHg), heart rate (bpm), respiratory rate (bpm), oxygen saturation (SpO2) using pulse oximeter, and fatigue level using Borg CR-10 were assessed before and after the 1MSTS. The blood pressure values were represented as mean arterial pressure (MAP). To determine the MAP, double the diastolic blood pressure, add this value to the systolic blood pressure, and then divide the total by three. During the test, the change in blood oxygen level was assessed for 1 min over the course of the test. The differences in heart rate, respiratory rate, SpO2 and fatigue score were calculated by subtracting the values before the test from those after the test.

Sample size calculation

The sample size for comparison between the post COVID-19 and non COVID-19 groups was calculated using the following formula for group comparison with an independent t-test (Wang & Ji, 2020):

n=2σ2(Z1−α/2+Z1−β)2(μ1−μ2)2

Based on the number of repetition of 1MSTS, Z1−α/2=1.96, Z1−β=1.645,μ1−μ2=6.7,andσ2=40.96 (Peroy-Badal et al., 2024), the required sample size was calculated to be 29. In considering 25% drop out, the required sample size was increased to 36 persons per group. When calculating the effect size using G*power, it was found to be 0.51, indicating that the magnitude of the outcome difference is moderate between the post-COVID-19 patients and the non-COVID-19 group.

Statistical analysis

Data analysis was performed using SPSS Version 26.0, with statistical significance set at p < 0.05. There were no missing data for any parameters. Descriptive statistics were used to analyze the general characteristics of the participants, including age, gender, BMI, and physical activity level. The Shapiro-Wilk test was employed to assess the normality of all variables. For comparing body composition, physical fitness, and quality of life between groups, the Mann-Whitney U test was used for non-normally distributed data, while the independent t-test was used for normally distributed data. For comparing sleep quality (categorical data), the Chi-square test was used.

Results

Out of a total of 267 volunteers, 128 had been exposed to COVID-19, representing 47.9%. Out of the 128 that had been exposed, 36 post COVID-19 patients (28.1%) had passed the inclusion criteria, whereas 92 were excluded due to asymptomatic COVID-19. Of the 72 participants in the study, 36 had never been infected with COVID-19 and 36 had been infected with COVID-19. Most of the participants were female (80.6%), with light physical activity levels (75%), and non-smokers (97.2%). In addition, 69.4% of the post COVID-19 group and 63.9% of the non COVID-19 group did not get enough sleep during the night. Regarding quarantine as a high-risk group, 75% of the post COVID-19 group and 58.3% of the non COVID-19 group had been quarantined as a high-risk group. Additionally, there was no statistically significant difference between the two groups, as shown in Table 1.

10.7717/peerj.18074/table-1 Table 1 General characteristics of the participants in the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups.

General characteristics	Non COVID-19 (n = 36)	Post COVID-19 (n = 36)	p-value	
Mean ± SD	Range	n (%)	Mean ± SD	Range	n (%)	
Age (yrs)	19.58 ± 1.10	18–21		19.62 ± 1.09	18–21		0.811	
Gender							1.000	
– Male			7 (19.4)			7 (19.4)		
– Female			29 (80.6)			29 (80.6)		
BMI (kg/m2)	20.53 ± 1.38	18.16–22.75		20.04 ± 1.55	18.00–22.74		0.884	
Waist circumference (cm)	68.75 ± 4.43	60–82		68.73 ± 4.26	60–82		0.978	
Physical activity level							0.810	
Light			27 (75.0)			27 (75.0)		
Moderate			6 (16.7)			6 (16.7)		
High			3 (8.3)			3 (8.3)		
Sleep duration during the past year (hrs)	6.39 ± 1.10	5–10		6.43 ± 1.13	4–10		0.637	
General characteristics	n (%)	p-value	
Non COVID-19
(n = 36)	Post COVID-19
(n = 36)	
Sleep quality			0.620	
Adequate	13 (36.1)	11 (30.6)		
Not adequate	23 (63.9)	25 (69.4)		
Smoking behaviors			0.984	
Non-smoker	35 (97.2)	35 (97.2)		
Smoker	1 (2.8)	1 (2.8)		
Secondary smoker			0.227	
Yes	16 (44.4)	11 (30.6)		
No	20 (55.6)	25 (69.4)		
Understand COVID-19			0.317	
Yes	36 (100)	35 (97.2)		
No	0 (0)	1 (2.8)		
Practice following guideline for			0.055	
COVID-19				
Sometimes	18 (50.0)	10 (27.8)		
Strictly	18 (50.0)	26 (72.2)		
Number of vaccines received			0.317	
0	0 (0)	1 (2.8)		
2	22 (61.1)	17 (47.2)		
3	10 (27.8)	15 (41.7)		
4	4 (11.1)	3 (8.3)		
Quarantine as a high-risk group			0.136	
Yes	21 (58.3)	27 (75.0)		
No	15 (41.7)	9 (25.0)		
Note:

BMI, body mass index.

General characteristics of the post COVID-19 participants (n = 36)

From the group of post COVID-19 participants, 88.9% had been infected only 1 time, and 52.8% didn’t know the cause of infection. While infected with COVID-19, the majority (80.6%) experienced only mild symptoms, with the highest number of symptoms at 12; and the most common symptom was sore throat followed by cough and fever, as shown in Table 2.

10.7717/peerj.18074/table-2 Table 2 Characteristics of the post COVID-19 participants (n = 36).

Characteristics	n (%)	
How many times you have been infected with COVID-19		
1 time	32 (88.9)	
2 times	4 (11.1)	
Do you know the cause of COVID-19 infection		
Yes	17 (47.2)	
No	19 (52.8)	
Drug received during COVID-19 infection		
Symptomatic medication	26 (72.2)	
Favipiravir with symptomatic medication	10 (27.8)	
Place of treatment during COVID-19 infection		
Home quarantine	9 (25.0)	
Quarantine in the community or university	8 (22.2)	
Hospital	1 (2.8)	
Hospital	18 (50.5)	
How many symptoms you have during COVID-19 infection		
3	1 (2.8)	
4	3 (8.3)	
5	8 (22.2)	
6	5 (13.9)	
7	2 (5.6)	
8	4 (11.1)	
9	5 (13.9)	
10	2 (5.6)	
11	4 (11.1)	
12	2 (5.6)	
Symptom during COVID-19 infection		
Sore throat	35 (97.2)	
Cough	33 (91.7)	
Fever	30 (83.8)	
Chest pain
Dyspnea	9 (25.0)
12 (33.3)	
Hair loss	15 (41.7)	
Fatigue	27 (75.0)	
Loss of taste	10 (27.8)	
Loss of smell	7 (19.4)	
Headache	23 (63.9)	
Nausea/Vomiting	8 (22.2)	
Diarrhea	11 (30.6)	
Insomnia	12 (33.3)	
Muscle ache	23 (63.9)	
Confusion	5 (13.9)	
Memory problem	4 (11.1)	
Runny or stuffy nose	1 (2.8)	

Body composition between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups

Body composition composed of body fat, muscle mass, visceral fat levels, lean body mass, and total body water. It was found that there was no statistically significant difference in all parameters of the body composition between the post COVID-19 and non COVID-19 groups, as shown in Table 3.

10.7717/peerj.18074/table-3 Table 3 Comparison of body composition of the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups.

Body composition	Non COVID-19 (n = 36)	Post COVID-19 (n = 36)	p-value	
Mean ± SD	Median (Quartile 1–3)	Mean ± SD	Median (Quartile 1–3)	
Body fat (%)	22.28 ± 5.75	24.65 (19.37–27.35)	23.02 ± 6.26	24.75 (20.02–27.12)	0.875a	
Muscle mass (kg)	37.85 ± 4.91	36.55 (34.62–39.10)	38.21 ± 5.34	36.85 (34.87–40.02)	0.604a	
Visceral fat level	–	2 (1–3)	–	2 (1–3)	0.725a	
Lean body mass (kg)	37.08 ± 4.55	36.40 (34.04–37.97)	37.42 ± 4.88	36.41 (34.97–38.55)	0.569a	
Total body water (%)	51.83 ± 3.52	51.29 (48.95–53.14)	58.42 ± 17.02	52.09 (49.09–57.69)	0.265a	
Note:

a Mann-Whitney U test was used.

Physical fitness between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups

From the physical fitness test evaluating the strength of the hand muscles and assessing the 1MSTS, changes were detected in the heart rate, respiratory rate, blood oxygen saturation, and blood pressure pre and post 1MSTS test.

When compared between the post COVID-19 and non COVID-19 groups, the change of respiratory rate and blood oxygen saturation exhibited a statistically significant difference (p = 0.003 and p = 0.006, respectively), as shown in Table 4.

10.7717/peerj.18074/table-4 Table 4 Comparison of physical fitness between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups.

Physical fitness	Non COVID-19
(n = 36)	Post COVID-19
(n = 36)	p-value	
Mean ± SD	Range/Median (Quartile 1–3)	Mean ± SD	Range/Median (Quartile 1–3)		
Grip strength (kg/BW)	0.51 ± 0.10	0.34–0.82	0.49 ± 0.10	0.31–0.77	0.528b	
Δ Heart rate (bpm)	46.11 ± 14.58	22–90	40.53 ± 12.70	11–65	0.121b	
MAP before 1MSTS (mmHg)	73.30 ± 6.94	60.00–86.00	73.42 ± 9.20	52.00–106.66	0.913b	
MAP after 1MSTS (mmHg)	76.39 ± 8.55	60.00–96.33	76.48 ± 9.50	55.33–101.33	0.461b	
1MSTS (time)	29.31 ± 6.63	30 (24.62–34.87)	29.66 ± 6.49	28.75 (25–34.75)	0.866a	
Δ Respiratory rate (bpm)	6.42 ± 1.79	6 (5–7.75)	7.06 ± 1.95	8 (6.25–9)	0.003a*	
Δ SpO2 (%)	0.89 ± 0.70	1 (0–1)	1.15 ± 0.83	1 (1–2)	0.006a*	
Δ Fatigue score	1.59 ± 1.22	1.25 (1–2.37)	1.43 ± 1.17	1 (0.5–2)	0.238a	
Notes:

* Significance at p < 0.05.

a Mann-Whitney U test was used.

b Independent samples T-test was used.

MAP, mean arterial pressure; 1MSTS, 1-min sit-to-stand test; SpO2, peripheral blood oxygen saturation.

Sleep quality between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups

A statistically significant difference was found between the post-COVID-19 and non-COVID-19 groups in terms of sleep quality. The non COVID-19 group had a similar proportion of people with good and poor sleep quality, but the majority of the post-COVID-19 participants had poor sleep quality (80.6%), as indicated in Table 5.

10.7717/peerj.18074/table-5 Table 5 Comparison of sleep quality between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups.

Sleep quality	n (%)		
Non COVID-19 (n = 36)	Post COVID-19 (n = 36)	p-value	
Good sleep quality (>5)	19 (52.8)	7 (19.4)	0.003a*	
Poor sleep quality (≤5)	17 (47.2)	29 (80.6)		
Notes:

a Chi-square test was used.

* Significance at p < 0.05.

Quality of life between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups

When quality of life was compared between the post-COVID-19 and non COVID-19 groups, there was no statistically significant difference (Table 6).

10.7717/peerj.18074/table-6 Table 6 Comparison of quality of life between the post COVID-19 (n = 36) and non COVID-19 (n = 36) groups.

Quality of life	n (%)	p-value	
Non COVID-19 (n = 36)	Post COVID-19 (n = 36)	
– Not perfect health

	19 (52.8)	20 (55.6)	0.814a	
– Perfect health

	17 (47.2)	16 (44.4)		
Note:

a Mann-Whitney U test was used.

Discussion

The purpose of this study was to determine the impact of COVID-19 on body composition, physical fitness, sleep quality and quality of life. There was no statistically significant difference in all parameters of body composition (body fat, muscle mass, visceral fat, lean body mass and total body water) between the post COVID-19 and non COVID-19 groups, contradicting the previous studies that post COVID-19 group had statistically significant increase in body fat (Atieh et al., 2024; Peball et al., 2024) and decrease in muscle mass (Montes-Ibarra et al., 2023). This might be because the previous study had recruited participants who had been infected for more than 3 months, but the participants of the post COVID-19 group in this study had been infected for less than 3 months (average 50 days). Therefore, that the long duration after infection might have influenced the change in body composition. It might be interesting to follow up with the post COVID-19 group for more than 3 months. Furthermore, this might be attributable to the specific strain of SARS-CoV-2. During the data collection period, the dominant SARS-CoV-2 strains circulating in Thailand were primarily from the Omicron variant, particularly subvariants BA.1 and BA.2. These subvariants generally cause milder illness and less frequent loss of taste and smell compared to earlier variants like Delta (WHO, 2024). However, this study did not record the SARS-CoV-2 strain, so future research should identify the strain to better understand its impact on the outcomes.

The number of times to get up and sit for 1 min was not significantly different between the post COVID-19 and non COVID-19 groups. The post COVID-19 group had a greater decrease in blood oxygen saturation (SpO2) after the 1MSTS than the non COVID-19 group. SpO2 was measured using pulse oximetry, which provides a convenient, noninvasive method to measure blood oxygen saturation continuously. It can also help to eliminate medical errors. Pulse oximetry has a sensitivity of 92% and a specificity of 90% (Hafen & Sharma, 2022). Among the post COVID-19 group, pneumonia developed during the acute stage of infection (Peter et al., 2020) and decreased lung function due to a change in the structure of the lungs. It was found that lung elasticity was reduced by post-inflammatory fibrosis resulting in an uneven distribution of capillaries (Rana et al., 2021), causing breathing difficulties so that the exchange of oxygen in the blood was reduced. However, the difference was not clinically significant for detecting exercise-induced desaturation. A decrease in oxygen saturation of three percentage points or more during the test was considered clinically significant for detecting exercise-induced desaturation (Briand et al., 2018).

In addition, there was a statistically significant difference in the respiratory rate (p < 0.05) after the 1-min sit-to stand test, with those who had post COVID-19 showing a higher change in respiratory rate compared to those who had not been exposed to COVID-19. The respiratory rate is a specific and early indicator of physiological conditions like hypoxia and hypercapnia, highlighting its importance in identifying patient deterioration and prompting timely intervention. This is because dyspnea is a common residual symptom after exposure to COVID-19 (Nalbandian et al., 2021), even in mild cases. This was consistent with a previous study of hyperventilation in patients who had been exposed to COVID-19 with mild symptoms, and it was found that patients who had been exposed to COVID-19 had increased breathing rate and decreased ability to exercise during cardiopulmonary function tests (Motiejunaite et al., 2020).

From this study, it was found that there was no difference in hand grip strength between the post COVID-19 and non COVID-19 groups. This might be due to the participants’ symptoms at the time of exposure to COVID-19 were mild or classified as a green patient group. This contradicted a study by Tanrıverdi et al. (2021) who investigated physical fitness in people who had been exposed to COVID-19 with mild and moderate symptoms, and it was found that the group with mild symptoms had a slight decrease in muscle strength compared to the moderate group. The hand grip strength of both groups in this study was found to be moderate and there was only a 0.02 between-group difference, which was lower than the minimal clinically important difference (MCID = 0.04–0.7) (Bohannon, 2019).

There was a statistically significant difference in sleep quality between the post COVID-19 and non COVID-19 groups (p < 0.05). The non COVID-19 group had better sleep quality than the post COVID-19 group. This could be related to COVID-19 exposure, which impacted breathing difficulties and anxiety. Patients who had to be quarantined and separated from their family members could experience greater anxiety (Souza et al., 2021). According to a previous study, tension and depression were associated with poor sleep quality. In addition, insufficient sleep might have negative effects on the body such as fatigue, palpitations, irritability, headache (Ingram, Maciejewski & Hand, 2020) and stress (Mekhael et al., 2022).

This study found that quality of life had no significant difference between the post COVID-19 and non COVID-19 groups (p > 0.05). This could be because the study used a matched-pair design, where individuals with similar levels of physical activity were paired together. As a result, this pairing might lead to no noticeable differences in the quality of life between the two groups using EuroQol-5D-5L.

This study had several limitations. First, body composition can vary between genders; thus, future research should consider including only one gender to avoid this variability. Second, anxiety, depression and drug use may influence sleep quality and quality of life; therefore, further study should either collect information on or exclude cases with other factors that might affect sleep quality and quality of life. Third, this study recruited participants who had been diagnosed with COVID-19 and had recovered or completed the quarantine period within 1–3 months after being infected. Given that the post COVID-19 or long Covid condition is defined as the period extending beyond 1 month after COVID-19 infection, further study should include participants who took more than 3 months to recover or complete their quarantine period to provide a comprehensive analysis of the long-term effects of the novel coronavirus. Fourth, the non COVID-19 group was not confirmed for COVID-19 status through PCR or antibody tests in this study. There is a possibility that some asymptomatic individuals with COVID-19 were included in the control group. Future research should include verification of COVID-19 status using PCR or antibody tests to ensure the integrity of the control group. Fifth, this study did not account for other confounding factors such as chronic diseases and vaccination status when matching groups, which may impact the reliability of the comparisons made. Future studies should include these additional confounding factors when matching groups to enhance the accuracy of the results. Sixth, this study may have a small sample size. To increase the test’s power, future research should be conducted with a larger sample size. Lastly, the study was a cross-sectional study that did not establish a true cause-and-effect relationship. Further studies should follow up with the participants over time to establish a causal relationship.

Conclusions

COVID-19 impacted sleep quality and led to changes in blood oxygen saturation and breathing rate. The results of this study should be utilized for COVID-19-infected individuals’ physical rehabilitation following infection. Those who have not been infected with COVID-19 should be informed of self-protection measures to avoid contracting the disease. Although a statistically significant difference was identified, it was not clinically significant for detecting exercise-induced desaturation and changes in breathing rate. Thus, these results should be used with caution.

Supplemental Information

10.7717/peerj.18074/supp-1 Supplemental Information 1 Questionnaire.

10.7717/peerj.18074/supp-2 Supplemental Information 2 STROBE checklist.

10.7717/peerj.18074/supp-3 Supplemental Information 3 Raw data.

We would like to thank all participants for their effective cooperation in this study.

Additional Information and Declarations

Competing Interests

Author Contributions

Human Ethics

Data Availability

The authors declare that they have no competing interests.

Phatcharawadee Srirug conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

Chatkaew Pongmala analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

Balkis Mayeedeng performed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

Nurulfatin Yusoh performed the experiments, prepared figures and/or tables, and approved the final draft.

Sofiya Malee performed the experiments, prepared figures and/or tables, and approved the final draft.

Chadayu Udom conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

The Walailak University granted Ethical approval to carry out the study within its facilities (Ethical Application Ref: WUEC-22-204-01).

The following information was supplied regarding data availability:

The raw data is available in the Supplemental File.
==== Refs
References

Atieh et al. (2024) Atieh O Durieux JC Baissary J Mouchati C Labbato D Thomas A Merheb A Ailstock K Funderburg N McComsey GA The long-term effect of COVID-19 infection on body composition Nutrients 2024 16 9 1364 10.3390/nu16091364 38732609
Bohannon (2019) Bohannon RW Minimal clinically important difference for grip strength: a systematic review Journal of Physical Therapy Science 2019 31 1 75 78 10.1589/jpts.31.75 30774209
Bohannon & Crouch (2019) Bohannon RW Crouch R 1-minute sit-to-stand test: systematic review of procedures, performance, and clinimetric properties Journal of Cardiopulmonary Rehabilitation and Prevention 2019 39 1 2 8 10.1097/HCR.0000000000000336 30489442
Briand et al. (2018) Briand J Behal H Chenivesse C Wémeau-Stervinou L Wallaert B The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease Therapeutic Advances in Respiratory Disease 2018 12 1753466618793028 10.1177/1753466618793028 30091679
Bryson (2021) Bryson WJ Long-term health-related quality of life concerns related to the COVID-19 pandemic: a call to action Quality of Life Research 2021 30 3 643 645 10.1007/s11136-020-02677-1 33073307
Cirulli et al. (2020) Cirulli ET Schiabor Barrett KM Riffle S Bolze A Neveux I Dabe S Grzymski JJ Lu JT Washington NL Long-term COVID-19 symptoms in a large unselected population medRxiv 2020 10.1101/2020.10.07.20208702
Ding et al. (2020) Ding H Yin S Cheng Y Cai Y Huang W Deng W Neurologic manifestations of nonhospitalized patients with COVID‐19 in Wuhan, China MedComm 2020 1 2 253 256 10.1002/mco2.13 34172986
Hafen & Sharma (2022) Hafen BB Sharma S Oxygen Saturation 2022 https://www.ncbi.nlm.nih.gov/books/NBK525974/ (accessed 23 November 2022)
Ingram, Maciejewski & Hand (2020) Ingram J Maciejewski G Hand CJ Changes in diet, sleep, and physical activity are associated with differences in negative mood during COVID-19 lockdown Frontiers in Psychology 2020 11 588604 10.3389/fpsyg.2020.588604 32982903
Kimman et al. (2013) Kimman M Vathesatogkit P Woodward M Tai ES Thumboo J Yamwong S Ratanachaiwong W Wee HL Sritara P Validity of the Thai EQ-5D in an occupational population in Thailand Quality of Life Research 2013 22 6 1499 1506 10.1007/s11136-012-0251-2 22926727
Ladds et al. (2020) Ladds E Rushforth A Wieringa S Taylor S Rayner C Husain L Greenhalgh T Persistent symptoms after Covid-19: qualitative study of 114 “long Covid” patients and draft quality principles for services BMC Health Services Research 2020 20 1144 10.1186/s12913-020-06001-y 33342437
Mekhael et al. (2022) Mekhael M Lim CH El Hajjar AH Noujaim C Pottle C Makan N Dagher L Zhang Y Chouman N Li DL Ayoub T Marrouche N Studying the effect of long COVID-19 infection on sleep quality using wearable health devices: observational study Journal of Medical Internet Research 2022 24 7 e38000 10.2196/38000 35731968
Montes-Ibarra et al. (2023) Montes-Ibarra M Orsso CE Limon-Miro AT Gonzalez MC Marzetti E Landi F Heymsfield SB Barazzoni R Prado CM Prevalence and clinical implications of abnormal body composition phenotypes in patients with COVID-19: a systematic review The American Journal of Clinical Nutrition 2023 117 6 1288 1305 10.1016/j.ajcnut.2023.04.003 37037395
Motiejunaite et al. (2020) Motiejunaite J Balagny P Arnoult F Mangin L Bancal C d’Ortho MP Frija-Masson J Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Frontiers in Physiology 2020 11 614590 10.3389/fphys.2020.614590 33536937
Nalbandian et al. (2021) Nalbandian A Sehgal K Gupta A Madhavan MV McGroder C Stevens JS Cook JR Nordvig AS Shalev D Sehrawat TS Ahluwalia N Bikdeli B Dietz D Der-Nigoghossian C Liyanage-Don N Rosner GF Bernstein EJ Mohan S Beckley AA Seres DS Choueiri TK Uriel N Ausiello JC Accili D Freedberg DE Baldwin M Schwartz A Brodie D Garcia CK Elkind MSV Connors JM Bilezikian JP Landry DW Wan EY Post-acute COVID-19 syndrome Nature Medicine 2021 27 4 601 615 10.1038/s41591-021-01283-z
Peball et al. (2024) Peball M Rass V Valent D Beer R Schiefecker AJ Limmert V Putnina L Heim B Ellmerer P Carbone F Mahlknecht P Kofler M Lindner A Kindl P Sahanic S Coen M Pizzini A Pfausler B Kiechl S Sonnweber T Tancevski I Löffler-Ragg J Djamshidian A Helbok R Seppi K Body composition and physical performance 1 year after COVID-19 American Journal of Physical Medicine & Rehabilitation 2024 103 2 124 133 10.1097/phm.0000000000002314 37408132
Peroy-Badal et al. (2024) Peroy-Badal R Sevillano-Castaño A Torres-Castro R García-Fernández P Maté-Muñoz JL Dumitrana C Sánchez Rodriguez E de Frutos Lobo MJ Vilaró J Comparison of different field tests to assess the physical capacity of post-COVID-19 patients Pulmonology 2024 30 1 17 23 10.1016/j.pulmoe.2022.07.011 36117103
Peter et al. (2020) Peter MG Shaney LB Robin C Sujal RD Anand D Ian F Michael AG Nicholas H Jenkins RG Danny FM Brijesh VP Erica T Lisa GS Respiratory follow-up of patients with COVID-19 pneumonia Thorax 2020 75 11 1009 1016 10.1136/thoraxjnl-2020-215314 32839287
Rana et al. (2021) Rana R Tripathi A Kumar N Ganguly NK A comprehensive overview on COVID-19: future perspectives Frontiers in Cellular and Infection Microbiology 2021 11 744903 10.3389/fcimb.2021.744903 34595136
Rudroff et al. (2020) Rudroff T Fietsam AC Deters JR Bryant AD Kamholz J Post-COVID-19 fatigue: potential contributing factors Brain Sciences 2020 10 12 1012 10.3390/brainsci10121012 33352638
Santus et al. (2020) Santus P Tursi F Croce G Di Simone C Frassanito F Gaboardi P Airoldi A Pecis M Negretto G Radovanovic D Changes in quality of life and dyspnoea after hospitalization in COVID-19 patients discharged at home Multidisciplinary Respiratory Medicine 2020 15 1 713 10.4081/mrm.2020.713 33117535
Shanbehzadeh et al. (2021) Shanbehzadeh S Tavahomi M Zanjari N Ebrahimi-Takamjani I Amiri-arimi S Physical and mental health complications post-COVID-19: scoping review Journal of Psychosomatic Research 2021 147 1 110525 10.1016/j.jpsychores.2021.110525 34051516
Sharma, Bharti & Garg (2022) Sharma P Bharti S Garg I Post COVID fatigue: can we really ignore it? The Indian Journal of Tuberculosis 2022 69 2 238 241 10.1016/j.ijtb.2021.06.012 35379408
Sitasuwan et al. (2014) Sitasuwan T Bussaratid S Ruttanaumpawan P Chotinaiwattarakul W Reliability and validity of the Thai version of the Pittsburgh sleep quality index Journal of the Medical Association of Thailand 2014 97 Suppl 3 S57 67
Souza et al. (2021) Souza ASR Souza GFA Souza GA Cordeiro ALN Praciano GAF Alves ACdS Santos ACd Silva Junior JR Souza MBR Factors associated with stress, anxiety, and depression during social distancing in Brazil Revista De Saúde Pública 2021 55 5 10.11606/s1518-8787.2021055003152 33852675
Supadanaison, Panklang & Seechumsang (2019) Supadanaison R Panklang T Seechumsang J The design and creation of automatic body mass index (BMI) projecting by internet network I-TECH 2019 14 2 73 85
Tanrıverdi et al. (2021) Tanrıverdi A Savci S Kahraman BO Ozzpelit E Comparison of muscle strength, physical activity, mood and sleep quality in patients with recovered from mild and moderate COVID-19 European Respiratory Journal 2021 58 suppl 65 PA2268 10.1183/13993003.congress-2021.PA2268
Tenforde et al. (2020) Tenforde MW Kim SS Lindsell CJ Rose EB Shapiro NI Files DC Gibbs KW Erickson HL Steingrub JS Smithline HA Gong MN Aboodi MS Exline MC Henning DJ Wilson JG Khan A Qadir N Brown SM Peltan ID Rice TW Hager DN Ginde AA Stubblefield WB Patel MM Self WH Feldstein LR Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network—United States, March–June 2020 Morbidity and Mortality Weekly Report 2020 69 993 998 10.15585/mmwr.mm6930e1 32730238
Wang & Ji (2020) Wang X Ji X Sample size estimation in clinical research: from randomized controlled trials to observational studies Chest 2020 158 1, Supplement S12 S20 10.1016/j.chest.2020.03.010 32658647
WHO (2020) WHO What we know about long-term effects of COVID-19 2020 Geneva, Switzerland World Health Organisation https://www.who.int/publications/m/item/update-36-long-term-effects-of-covid-19
WHO (2024) WHO COVID-19-WHO Thailand situation reports. Retrieved 31 May 2024 2024 https://www.who.int/thailand/emergencies/novel-coronavirus-2019/situation-reports
Worldometers (2024) Worldometers Coronavirus update (live): 704,753,890 cases and 7,010,681 deaths from COVID-19 virus pandemic 2024 https://www.worldometers.info/coronavirus/ (accessed 13 April 2024)
Zaccagni et al. (2020) Zaccagni L Toselli S Bramanti B Gualdi-Russo E Mongillo J Rinaldo N Handgrip strength in young adults: association with anthropometric variables and laterality International Journal of Environmental Research and Public Health 2020 17 12 4273 10.3390/ijerph17124273 32549283
Zhou et al. (2020) Zhou F Yu T Du R Fan G Liu Y Liu Z Xiang J Wang Y Song B Gu X Guan L Wei Y Li H Wu X Xu J Tu S Zhang Y Chen H Cao B Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020 395 10229 1054 1062 10.1016/S0140-6736(20)30566-3 32171076
